Physician

Vijay Singh, MD

According to 2025 Medicare claims, Vijay Singh, MD (NPI: 1174786297) practices rheumatology in the Camden, NJ market, with the plurality of this provider's patient population coming from Gloucester, NJ. This provider's primary affiliated billing organization is ADVOCARE, LLC (NPI: 1770538696; TIN: 223537011) and primary practice location at 08080-9478. Singh is affiliated with the Aledade 196 Advocare Collaborative Health MSSP (ACO ID: A5364), participating under the MSSP model.

Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 911 traditional Medicare patients, billed 200,202 HCPCS/CPT codes, and received $1,942,421 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 6,834 prescription claims across 1,181 beneficiaries totaling $6,931,791 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2022 DME data shows 11 claims. Open Payments data shows 116 records totaling $1,813. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	574	29,640	$448,265
2016	567	63,400	$805,279
2017	784	114,480	$1,530,668
2018	1,216	197,816	$2,819,457
2019	1,347	202,753	$2,812,730
2020	1,363	223,883	$3,138,471
2021	1,513	297,588	$3,923,110
2022	1,295	196,626	$2,286,950
2023	915	183,451	$1,917,950
2024	911	200,202	$1,942,421

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	510	3,750	$5,622,909
2016	526	3,734	$5,800,718
2017	660	4,322	$5,323,754
2018	1,135	6,192	$4,311,577
2019	1,350	7,162	$3,673,617
2020	971	5,969	$3,690,772
2021	886	5,215	$3,740,606
2022	1,039	5,987	$5,140,985
2023	1,040	6,198	$6,013,998
2024	1,181	6,834	$6,931,791

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	15	15	$11,301
2016	21	21	$15,648
2017	34	56	$27,810
2018	17	17	$12,961
2019	48	48	$37,438
2020	33	45	$25,656
2021	24	24	$14,950
2022	11	11	$6,918
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	139	219	$129
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	803	1,987	$94
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	284	1,018	$60
J0897	Injection, denosumab, 1 mg	218	20,940	$20
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	592	1,203	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	114	3,786	$920,378
Remicade	Infliximab	104	3,724	$779,196
Cimzia (2 Pack)	Certolizumab Pegol	88	2,842	$611,942
Benlysta	Belimumab	154	4,256	$508,189
Enbrel Sureclick	Etanercept	59	1,764	$466,501

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	116	$1,813	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vijay Singh, MD?

Tedicare shows public-source Medicare data for Vijay Singh, MD (NPI 1174786297), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vijay Singh, MD have ACO affiliation data?

Vijay Singh, MD is shown with ACO affiliation data for Aledade 196 Advocare Collaborative Health MSSP (MSSP, ACO ID A5364).

What billing organization is linked to Vijay Singh, MD?

Vijay Singh, MD is linked to ADVOCARE, LLC (billing NPI 1770538696) in the available physician profile data.

Does Vijay Singh, MD have Open Payments data?

Vijay Singh, MD has 116 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.